Almirall SA
Company Profile
Business description
Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company’s operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.
Contact
Ronda General Mitre 151
Barcelona08022
ESPT: +34 932913000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,984
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,741.90 | 26.70 | -0.30% |
CAC 40 | 7,804.87 | 14.60 | 0.19% |
DAX 40 | 24,304.46 | 19.12 | -0.08% |
Dow JONES (US) | 42,762.87 | 443.13 | 1.05% |
FTSE 100 | 8,837.91 | 26.87 | 0.30% |
HKSE | 24,092.21 | 299.67 | 1.26% |
NASDAQ | 19,529.95 | 231.51 | 1.20% |
Nikkei 225 | 38,137.09 | 395.48 | 1.05% |
NZX 50 Index | 12,529.42 | 34.06 | -0.27% |
S&P 500 | 6,000.36 | 61.06 | 1.03% |
S&P/ASX 200 | 8,515.70 | 23.20 | -0.27% |
SSE Composite Index | 3,396.59 | 11.24 | 0.33% |